The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys

Nature

Volumn 427, Issue 6977, 2004, Pages 848-853

  Stremlau, Matthew ^a   Owens, Christopher M ^a   Perron, Michel J ^a   Kiessling, Michael ^a   Autissier, Patrick ^a   Sodroski, Joseph ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODIVERSITY; BODY FLUIDS; DISEASES; IMMUNOLOGY; VIRUSES;

ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS); CELLULAR RESISTANCE;

CELLS;

COMPLEMENTARY DNA; CYTOPLASM PROTEIN; ISOPROTEIN; PROTEIN; TRIM5(ALPHA) PROTEIN, RHESUS MONKEY; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG;

BIOLOGY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; ARTICLE; CELL LINE; CHEMISTRY; CONTROLLED STUDY; CYTOPLASM; DISEASE PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HELA CELL; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MACACA; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIFFERENCE; VIROLOGY; VIRUS CAPSID; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CLONING, MOLECULAR; CYTOPLASMIC STRUCTURES; DISEASE SUSCEPTIBILITY; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN ISOFORMS; PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES SPECIFICITY; VARIATION (GENETICS); VIRUS REPLICATION;

ANIMALIA; CERCOPITHECIDAE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; PRIMATES; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 1542288934     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02343     Document Type: Article

References (30)

1. LaBonte, J., Babcock, G., Patel, T. & Sodroski, J. Blockade of human immunodeficiency virus (HIV-1) of New World monkey cells occurs primarily at the stage of virus entry. J. Exp. Med. 196, 431-435 (2002).
2. Shibata, R., Sakai, H., Kawamura, M., Tokunaga, K. & Adachi, A. Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol. 76, 2723-2730 (1995).
3. Himathongkham, S. & Luciw, P. A. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 219, 485-488 (1996).
4. Hofmann, W. et al. Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73, 10020-10028 (1999).
5. Owens, C. M., Yang, P. C., Gottlinger, H. & Sodroski, J. Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, post-entry replication blocks in simian cells. J. Virol. 77, 726-731 (2003).
6. Kootstm, N. A., Munk, C., Tonnu, N., Landau, N. R. & Verma, I. M. Abrogation of postentry restriction of HIV-1 based lentiviral vector transduction in simian cells. Proc. Natl Acad. Sci. USA 100, 1298-1303 (2003).
7. Cowan, S. et al. Cellular inhibitors with Fv-1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl Acad. Sci. USA 99, 11914-11919 (2002).
8. Besnier, C., Takeuchi, Y. & Towers, G. Restriction of lentivirus in monkeys. Proc. Natl Acad. Sci. USA 99, 11920-11925 (2002).
9. Munk, C., Brandt, S. M., Lucero, G. & Landau, N. R. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl Acad. Sci. USA 99, 13843-13848 (2002).
10. Kanki, P. J., Alroy, J. & Essex, M. Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science 230, 951-954 (1985).
11. Reddy, B. A., Etkin, L. D. & Freemont, P. S. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem. Sci. 17, 344-345 (1992).
12. Borden, K. L. RING fingers and B-boxes: zinc-binding protein-protein interaction domains. Biochem. Cell Biol. 76, 351-358 (1998).
13. Reymond, A. et al. The tripartite motif family identifies cell compartments. EMBO J. 20, 2140-2151 (2001).
14. Xu, L, et al. BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5δ. Exp. Cell Res. 288, 84-93 (2003).
15. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996).
16. mac virus that expresses the HIV-1 envelope glycoproteins. J. AIDS 5, 639-646 (1992).
17. Dorfman, T. & Gottlinger, H. G. The human immunodeficiency virus type I capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 8II. J. Virol. 70, 5751-5757 (1996).
18. Waterman, H., Levkowitz, G., Alroy, I. & Yarden, Y. The RING finger of c-CBL mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274, 22151-22154 (1999).
19. Owens, C. M. et al. Binding and susceptibility to post-entry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type I capsid. J. Virol. (in the press).
20. Fassati, A. & Goff, S. P. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75, 3626-3635 (2001).
21. Forshey, B. M., von Schwedler, U., Sundquist, W. I. & Aiken, C. Formation of a human immunodeficiency virus type I core of optimal stability is crucial for viral replication. J. Viral. 76, 5667-5677 (2002).
22. Schwartz, O., Maréchal, V., Friguet, B., Arenzana-Seisdedos, F. & Heard, J.-M. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72, 3845-3850 (1998).
23. Turelli, P. et al. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol Cell 7, 1245-1254 (2001).
24. Marcello, A. et al. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J. 22, 2156-2166 (2003).
25. Bonilla, W. V. et al. Effects of promyelocytic leukemia protein on virus-host balance. J. Virol. 76, 3810-3818 (2002).
26. Chee, A. V., Lopez, P., Pandolfi, P. P. & Roizman, B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77, 7101-7105 (2003).
27. Rhodes, D. A. et al. The 52,000 MW Ro/SS-A autoantigen in Sjogren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-γ inducible tripartite motif protein associated with membrane proximal structures. Immunology 106, 246-256 (2002).
28. Toniato, E. et al. TRIMS/GERP RING finger protein interacts with SOCS-1. J. Biol. Chem. 277, 37315-37322 (2002).
29. Mariani, R. et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31 (2003).
30. Butler, S., Hansen, M. S. T. & Bushman, F. A quantitative assay for HIV DNA integration in vivo. Nature Med. 7, 631-634 (2001).